Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure
NCT03923673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2022-08-02
Summary
Researchers are studying the safety and efficacy of a minimally invasive treatment called a pericardiotomy, which creates a small opening in the sac that surrounds the heart. Researchers will test the short and long term effects of this procedure by monitoring subjects heart function and symptoms.
Conditions
Interventions
- PROCEDURE
-
Pericardiotomy
The minimally invasive procedure that creates a small opening in the sac that surrounds the heart.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Barry A Borlaug, MD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-01
- Primary Completion
- 2020-10-15
- Completion
- 2020-10-15
Countries
- United States
Study Locations
More Related Trials
-
Treating Heart Failure With hPSC-CMs
NCT03763136 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362 ·Status: RECRUITING ·Phase: PHASE2
-
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
NCT05305911 ·Status: RECRUITING ·Phase: PHASE2
-
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
NCT07347197 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction
NCT02262078 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
NCT06979375 ·Status: RECRUITING ·Phase: PHASE2
-
SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.
NCT03366181 ·Status: COMPLETED
-
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
NCT06340048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart Failure Complicated by Cardiogenic Shock
NCT04369573 ·Status: TERMINATED ·Phase: PHASE4
-
Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care
NCT06832722 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure
NCT06955260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure
NCT06621576 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)
NCT04363697 ·Status: COMPLETED ·Phase: PHASE4
-
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT06560762 ·Status: RECRUITING ·Phase: PHASE1
-
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy
NCT05795400 ·Status: COMPLETED ·Phase: NA
-
Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
NCT05600387 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy
NCT00270387 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy
NCT00696410 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults
NCT04996719 ·Status: COMPLETED ·Phase: PHASE1
-
Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients
NCT03816306 ·Status: COMPLETED
-
Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic Cardiomyopathy
NCT04696328 ·Status: UNKNOWN ·Phase: PHASE1
-
Angiotensin-II Blockade in Mitral Regurgitation
NCT00587470 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery
NCT06251453 ·Status: UNKNOWN
-
Effect of Sacubitril-Valsartan on Cardiac Structure and Function
NCT06693674 ·Status: RECRUITING ·Phase: PHASE3
-
Exparel in Minimally Invasive Cardiac Surgery
NCT02008370 ·Status: TERMINATED ·Phase: PHASE4